Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Validity of observational evidence on putative risk and protective factors: appraisal of 3744 meta-analyses on 57 topics
Perrine Janiaud, Arnav Agarwal, Ioanna Tzoulaki, Evropi Τheodoratou, Konstantinos K. Tsilidis, Εvangelos Εvangelou, John P A Ioannidis (2021). Validity of observational evidence on putative risk and protective factors: appraisal of 3744 meta-analyses on 57 topics. , 19(1), DOI: https://doi.org/10.1186/s12916-021-02020-6.
Article147 days agoClinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016
Aviv Ladanie, Andreas M. Schmitt, Benjamin Speich, Florian Naudet, Arnav Agarwal, Tiago Pereira, Francesco Sclafani, Amanda K. Herbrand, Matthias Briel, Juan Martín-Liberal, Thomas Schmid, Hannah Ewald, John P A Ioannidis, Heiner C. Bucher, Benjamin Kasenda, Lars G. Hemkens (2020). Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016. , 3(11), DOI: https://doi.org/10.1001/jamanetworkopen.2020.24406.
Article147 days agoPREDIMED trial of Mediterranean diet: retracted, republished, still trusted?
Arnav Agarwal, John P A Ioannidis (2019). PREDIMED trial of Mediterranean diet: retracted, republished, still trusted?. , 364, DOI: https://doi.org/10.1136/bmj.l341.
Article147 days agoSingle pivotal trials with few corroborating characteristics were used for FDA approval of cancer therapies
Aviv Ladanie, Benjamin Speich, Matthias Briel, Francesco Sclafani, Heiner C. Bucher, Arnav Agarwal, John P A Ioannidis, Tiago Pereira, Benjamin Kasenda, Lars G. Hemkens (2019). Single pivotal trials with few corroborating characteristics were used for FDA approval of cancer therapies. , 114, DOI: https://doi.org/10.1016/j.jclinepi.2019.05.033.
Article147 days agoThe Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs
Aviv Ladanie, Benjamin Speich, Florian Naudet, Arnav Agarwal, Tiago Pereira, Francesco Sclafani, Juan Martín-Liberal, Thomas Schmid, Hannah Ewald, John P A Ioannidis, Heiner C. Bucher, Benjamin Kasenda, Lars G. Hemkens (2018). The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs. , 19(1), DOI: https://doi.org/10.1186/s13063-018-2877-z.
Article147 days ago